je.st
news
Tag: biotech
Justin Sullivan/Getty Images For a few holdouts, Mass. still isn't biotech center
2015-01-20 04:37:02| Biotech - Topix.net
Genetech, headquartered in south San Francisco, does not plan to open a research and development facility in the Boston area. "We do deals with Boston companies.
Tags: center
images
mass
justin
J&J, Takeda team up to open Israeli biotech incubator
2015-01-19 19:00:53| Biotech - Topix.net
A long-awaited biotechnology incubator sponsored by some of the health world's top companies has opened in the Weizmann Science Park. The FutuRx incubator announced last week that it was open for business - and that it had enrolled its first two members, life sciences start-ups Hepy Biosciences and XoNovo.
Tags: open
team
biotech
israeli
Biotech rivalry gets nasty in mudslinging battle over data
2015-01-18 14:23:40| Biotech - Topix.net
The hot competition in biotechnology, where scientists race to cure complex diseases, boiled over last week as a company seeking to treat a deadly muscle disorder made an unusual move: It publicly criticized a rival's data. All BioMarin Pharmaceuticals Inc. of San Rafael, Calif., did was show investors two slides to illustrate an argument that its trial results were superior to those of Sarepta Therapeutics Inc. of Cambridge, Mass.
5 Tiny Biotech Stocks to Own in 2015
2015-01-17 13:23:40| Biotech - Topix.net
Biotech stocks are among the market's riskiest, but investors willing to accept the potential for pipeline failure might consider owning these five small-cap biotech stocks in 2015. All five have intriguing therapies in late-stage clinical trials, and three have high-profile big-cap partners.
ALPS Puts Twist On Biotech Investing With Medical Breakthrough ETF
2015-01-15 12:16:17| Biotech - Topix.net
Health & Biotech Equities ETFs had an astounding 2014 with the NASDAQ Biotechnology index returning a stellar 34% in 2014 - emerging as the biggest winner among all the sectors. Despite overall valuation concerns in the early phase of the year, the sector moved along strongly on rising merger and acquisition activities, several important product approvals and label expansions, ever-increasing health care spending, an aging population and last but not least Obamacare.
Tags: medical
investing
puts
twist
Sites : [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] next »